Simultaneous Estimation of Racecadotril and Ofloxacin by Reverse Phase High Performance Liquid Chromatography Method in Pharmaceutical Dosage Forms.
Background: Racecadotril and Ofloxacin (RACIGYL- O) drug combination are used for the treatment of diarrhea. The drugs have been estimated individually in formulations but no method has been developed for simultaneous estimation of these two drugs as combination.
Objective: To develop and validate a high performance liquid chromatography method for the simultaneous estimation of Racecadotril and Ofloxacin in tablet dosage form.
Method: A WATERS C18 column (250 x 4.6mm, 5 μm) with mobile phase consisting of acetonitrile, methanol and water 40:40:20v/v (pH adjusted to 2.7 of water with ortho phosphoric acid). The flow rate was 1.0mL/min and effluents were monitored at 210nm.
Results: The retention time of RAC and OFL was 4.666 min and 2.551 min respectively. The developed method was validated according to ICH guidelines with respect to specificity, linearity, accuracy, precision, robustness, Limit of Detection (LOD) and Limit of Quantification (LOQ).
Conclusion: The method show good reproducibility and recovery with %RSD less than 2. So the proposed method was found to be simple, rapid, precise and accurate and useful for the determination of RAC and OFL in bulk and pharmaceutical dosage forms.
Keywords: RP-HPLC, Racecadotril, Ofloxacin, ICH guidelines.
 Laha TK, Patnaik R, Choudhury S, Sen S, Reverse phase high performance liquid chromatographic method for the analysis of Racecadotril in pharmaceutical dosage forms, Asian J Chem. 2008; 20:2575-2579.
 Indian Pharmacopoeia, Vol I, Controller of Publication, Delhi, 2.4.26 Solubility, 2014
 Patel DM, Soneji JA, Patel PB, Patel C, Development and validation of a method for simultaneous estimation of ofloxacin and ornidazole in different dissolution media, Pharm Methods. 2012; 3:102-105.
 Dhandapani B, Thirumoorthy N, Rasheed SH, Kotaiah MR, Anjaneyalu N., Method development and validation for the simultaneous estimation of ofloxacin and ornidazole in tablet dosage form by RP-HPLC, Int J Pharma Sci. 2010; 1(1):78-83.
 Drew RH, Gallis HA, Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical applications, Pharmacotherapy. 1988; 8:35-46.
 Swartz ME, Krull IS, Analytical method development and validation, J. Am. Chem. Soc . 1997; 22:104–119.
 Ahuja S, Rasmusssen H, HPLC method development for pharmaceuticals, First ed., Elsevier. 1997; 6:145–186.
 International conference on harmonization of technical requirements for registration of pharmaceuticals for human use ICH harmonized Tripartite Guideline on Validation of Analytical procedures: Text and Methodology Q2 R(1).
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).